Most life sciences transactions result in intellectual property (IP) due diligence being carried out on underlying IP assets that are often central to the transaction. Typically, this includes a focus on patent due diligence to determine whether key patent assets are valid and enforceable. For many life sciences companies, and particularly for early-stage companies, patent prosecution is proceeding at the same time as active due diligence….
By: Haynes Boone
By: Haynes Boone
